Anzeige
Meldung des Tages: Diese Entwicklung im KI-Sektor könnte unterschätzt werden — und sie betrifft die Energieversorgung

SCANNER TECH CORP News

Aktie
WKN:  A0CA37 ISIN:  US80603Q1058 US-Symbol:  SCNI
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

SCANNER TECH CORP News

01.04.26 - PR Newswire
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration PR Newswire
19.03.26 - PR Newswire
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-​Europe Spring® 2026 PR Newswire
16.03.26 - PR Newswire
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price PR Newswire
02.03.26 - PR Newswire
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-​Dilutive FENG Application to Advance PC111 Through Human Proof of Concept ...
25.02.26 - PR Newswire
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform PR Newswire
17.02.26 - PR Newswire
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm PR Newswire
07.01.26 - PR Newswire
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL PR Newswire
02.12.25 - PR Newswire
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
Scinai Reports Nine-​Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances PR Newswire
06.10.25 - PR Newswire
Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities
Scinai Awarded Israel Innovation Authority Grant to Expand Fill-​and-Finish CDMO Capabilities PR Newswire
02.09.25 - PR Newswire
Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet
Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet PR Newswire
29.07.25 - PR Newswire
Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN
Scinai Announces New Peer-​Reviewed Publication Supporting PC111 as a Disease-​Modifying Therapy for Pemphigus and SJS/TEN PR Newswire
26.06.25 - PR Newswire
Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology"
Scinai Highlights Award-​Winning Science Behind PC111 as Key Pincell Researcher Receives "Oscar of Italian Dermatology" PR Newswire
12.06.25 - PR Newswire
Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025
Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025 PR Newswire
05.06.25 - PR Newswire
Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.
Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l. PR Newswire
30.05.25 - PR Newswire
Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn
Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn PR Newswire
07.05.25 - PR Newswire
Scinai Announces Annual Financial Results for 2024
Scinai Announces Annual Financial Results for 2024 PR Newswire
01.05.25 - PR Newswire
Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases
Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases PR Newswire

Newssuche

Videos

newspaper
03.04.26
RW QUANTUM Strategie Einführung
Am Sonntag, den 12.4.26 wird erstmals die RW QUANTUM Strategie geschult. Der Ansatz handelt die ... Mehr »